| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Jia-Horng Kao | Q56850580 |
| P2093 | author name string | Chih-Lin Lin | |
| P2860 | cites work | Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus | Q21128797 |
| Novel double-antigen sandwich immunoassay for human hepatitis B core antibody | Q33526947 | ||
| Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B. | Q34007571 | ||
| The emerging role of hepatitis B virus pre-S2 deletion mutant proteins in HBV tumorigenesis. | Q34354947 | ||
| Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level | Q34481474 | ||
| Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients | Q34551114 | ||
| Global control of hepatitis B virus infection. | Q34749752 | ||
| Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease. | Q35197060 | ||
| Differential DNA methylation of genes involved in fibrosis progression in non-alcoholic fatty liver disease and alcoholic liver disease. | Q35337252 | ||
| Associations between pre-S deletion mutation of hepatitis B virus and risk of hepatocellular carcinoma in the Asian population: a meta-analysis | Q35541314 | ||
| Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan. | Q35612669 | ||
| Hepatitis B virus genotypes and variants. | Q35663838 | ||
| Antibody to hepatitis B core antigen levels in the natural history of chronic hepatitis B: a prospective observational study | Q36151658 | ||
| Hepatitis B virus core-related antigens as markers for monitoring chronic hepatitis B infection | Q36314552 | ||
| Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis | Q36545096 | ||
| Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers. | Q45376159 | ||
| Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients | Q45388432 | ||
| Role of hepatitis B virus genotype mixture, subgenotypes C2 and B2 on hepatocellular carcinoma: compared with chronic hepatitis B and asymptomatic carrier state in the same area | Q45397838 | ||
| Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients | Q45399837 | ||
| Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma | Q45402316 | ||
| Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B. | Q45461871 | ||
| Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. | Q45511057 | ||
| Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma | Q45540612 | ||
| Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients. | Q45891983 | ||
| Predicting cirrhosis risk based on the level of circulating hepatitis B viral load | Q46985831 | ||
| Looking into the crystal ball: biomarkers for outcomes of HBV infection. | Q48263897 | ||
| Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters. | Q51165652 | ||
| Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load. | Q51168753 | ||
| A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. | Q51732144 | ||
| Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B | Q57205485 | ||
| Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B | Q58235862 | ||
| Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent | Q77983359 | ||
| Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study | Q79832349 | ||
| Hepatitis B virus infection | Q83352950 | ||
| Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues. | Q36577343 | ||
| Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma | Q36841560 | ||
| DNA methylation profiling identifies novel markers of progression in hepatitis B-related chronic liver disease | Q36871793 | ||
| Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors | Q37039155 | ||
| Serum metabolomic signatures discriminate early liver inflammation and fibrosis stages in patients with chronic hepatitis B. | Q37157397 | ||
| Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms. | Q37192623 | ||
| Different pre-S deletion patterns and their association with hepatitis B virus genotypes | Q37267283 | ||
| Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis | Q37289608 | ||
| Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects | Q37804991 | ||
| Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report | Q37896235 | ||
| Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J. | Q38113175 | ||
| Hepatitis B viral factors and treatment responses in chronic hepatitis B. | Q38115875 | ||
| Perspectives and control of hepatitis B virus infection in Taiwan. | Q38549024 | ||
| Hepatitis B vaccination and prevention of hepatocellular carcinoma. | Q38664222 | ||
| Hepatitis B Virus (HBV) Core-Related Antigen During Nucleos(t)ide Analog Therapy Is Related to Intra-hepatic HBV Replication and Development of Hepatocellular Carcinoma | Q38815530 | ||
| Natural history of chronic HBV infection in West Africa: a longitudinal population-based study from The Gambia | Q39457688 | ||
| Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load | Q39681674 | ||
| Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load | Q39746604 | ||
| Quantitative maternal hepatitis B surface antigen predicts maternally transmitted hepatitis B virus infection. | Q39864436 | ||
| Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers. | Q39896037 | ||
| Serum HBV core-related antigen is a good predictor for spontaneous HBeAg seroconversion in chronic hepatitis B patients | Q40582667 | ||
| HBcrAg predicts hepatocellular carcinoma development: An analysis using time-dependent receiver operating characteristics | Q40732982 | ||
| The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B. | Q40880775 | ||
| Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D. | Q41472788 | ||
| Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance | Q41637137 | ||
| Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B. | Q42183506 | ||
| Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers. | Q42222443 | ||
| Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters | Q42245695 | ||
| Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma | Q42255811 | ||
| Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention | Q42271345 | ||
| Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. | Q42436412 | ||
| Hepatitis B: liver fibrosis and hepatocellular carcinoma | Q42456421 | ||
| Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers | Q42492983 | ||
| Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study. | Q42499453 | ||
| Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. | Q42505189 | ||
| Effect of nucleos(t)ide analogue therapy on hepatocarcinogenesis in chronic hepatitis B patients: a propensity score analysis | Q42515392 | ||
| Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B. | Q42780978 | ||
| Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death | Q43180169 | ||
| Measurement of hepatitis B virus core-related antigen is valuable for identifying patients who are at low risk of lamivudine resistance | Q43569399 | ||
| Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles. | Q43973491 | ||
| Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. | Q44021728 | ||
| High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load | Q44245742 | ||
| Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers | Q44745645 | ||
| Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients | Q45236945 | ||
| Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads | Q45355080 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial | Q6936496 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| chronic hepatitis B | Q55779876 | ||
| chronic hepatitis | Q62019625 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 423-431 | |
| P577 | publication date | 2016-12-01 | |
| 2016-12-25 | |||
| P1433 | published in | Clinical and molecular hepatology | Q26853927 |
| P1476 | title | New perspectives of biomarkers for the management of chronic hepatitis B | |
| P478 | volume | 22 |
| Q64121773 | Comparison between chronic hepatitis B patients with untreated immune-tolerant phase vs. those with virological response by antivirals |
| Q64254614 | Establishment of an analysis model based on measurement of hepatitis B viral infection serum markers |
| Q98498400 | Evaluation of HBV serological markers in treatment-naïve HBV mono-infected patients and HBV-HIV co-infected patients |
| Q59355831 | Global HBV burden: guesstimates and facts |
| Q58548875 | HBV induces inhibitory FcRL receptor on B cells and dysregulates B cell-T follicular helper cell axis |
| Q47937418 | Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace |
| Q54217690 | Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients? |
| Q94467538 | Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase |
| Q40172883 | Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia. |
| Q89551187 | Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi |
| Q92156002 | Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals |
| Q91924867 | The Role of Hepatitis B Core-Related Antigen |
| Q92666635 | The epidemiology of hepatitis B virus infection in Korea |
| Q45324577 | Unmet Needs in Clinical and Basic Hepatitis B Virus Research. |
| Q90150816 | Zeaxanthin Dipalmitate in the Treatment of Liver Disease |
Search more.